CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
66.06
-2.08 (-3.05%)
At close: Jul 24, 2025, 4:00 PM
66.35
+0.29 (0.44%)
After-hours: Jul 24, 2025, 7:58 PM EDT
CRISPR Therapeutics AG Analyst Ratings
Total Analysts
16
Consensus Rating
Buy
Price Target
$70.73
Upside
+7.07%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $79 → $78 | Strong Buy | Maintains | $79 → $78 | +18.07% | Jul 22, 2025 |
| Needham | Needham | Strong Buy Reiterates $81 | Strong Buy | Reiterates | $81 | +22.62% | Jul 8, 2025 |
| Clear Street | Clear Street | Strong Buy → Hold Downgrades $45 | Strong Buy → Hold | Downgrades | $45 | -31.88% | Jun 27, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $105 | Buy | Reiterates | $105 | +58.95% | Jun 27, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $86 | Buy | Reiterates | $86 | +30.18% | Jun 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $65 | Strong Buy | Reiterates | $65 | -1.60% | Jun 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $81 | Strong Buy | Reiterates | $81 | +22.62% | Jun 26, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $82 | Strong Buy | Maintains | $82 | +24.13% | Jun 26, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $86 | Buy | Reiterates | $86 | +30.18% | May 21, 2025 |
| Needham | Needham | Strong Buy Reiterates $81 | Strong Buy | Reiterates | $81 | +22.62% | May 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $65 | Strong Buy | Reiterates | $65 | -1.60% | May 20, 2025 |
| Barclays | Barclays | Hold Maintains $56 → $42 | Hold | Maintains | $56 → $42 | -36.42% | May 9, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $53 → $47 | Hold | Maintains | $53 → $47 | -28.85% | May 8, 2025 |
| Needham | Needham | Strong Buy Maintains $84 → $81 | Strong Buy | Maintains | $84 → $81 | +22.62% | May 7, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $84 → $82 | Strong Buy | Maintains | $84 → $82 | +24.13% | May 7, 2025 |
| Needham | Needham | Strong Buy Reiterates $84 | Strong Buy | Reiterates | $84 | +27.16% | Apr 9, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.